Efficacy of a Multiplex BangasureTM RT-PCR Kit for the Detection of COVID-19

Plain-language summary

This study evaluated the effectiveness of the multiplex BangasureTM RT-PCR test kit for detecting COVID-19. It compared samples with positive RT-PCR results (COVID-19 positive) and negative results using this new test kit. This study has no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

DR. MALA KHAN

Start date

6/1/2022

Estimated completion

9/15/2022

Countries

Bangladesh

Related genes

Locations

• Dhaka, Bangladesh

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Samples with Positives RT-PCR results with Ct value≤35 for the COVID-19 genes at IEDCR will be selected as COVID-19 positive.
* Samples with negative RT-PCR results with no amplification for the COVID-19 genes at IEDCR will be selected as COVID-19.

Exclusion Criteria:

* Samples with equivocal/ambiguous RT-PCR results in terms of sigmoidal curve and Ct value will be excluded.